GA

Geneva Advisors Portfolio holdings

AUM $5.81B Turnover 22.5%
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.58%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.12B
AUM Growth
-$199M
Cap. Flow
-$200M
Cap. Flow %
-3.9%
Top 10 Hldgs %
24.54%
Holding
885
New
102
Increased
287
Reduced
309
Closed
94
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$25.9M
2
CFG icon
Citizens Financial Group
CFG
+$23.8M
3
EOG icon
EOG Resources
EOG
+$23.7M
4
IBTX icon
Independent Bank Group, Inc.
IBTX
+$18.4M
5
AYI icon
Acuity Brands
AYI
+$17.8M

Top Sells

Rank Stock Value
1
BEAV
B/E Aerospace Inc
BEAV
+$48.6M
2
VTR icon
Ventas
VTR
+$42.2M
3
CNC icon
Centene
CNC
+$38.9M
4
MANH icon
Manhattan Associates
MANH
+$30.4M
5
CRM icon
Salesforce
CRM
+$24.4M

Sector Composition

Rank Sector Weight
1 Healthcare 16.09%
2 Financials 14.79%
3 Technology 14.28%
4 Consumer Discretionary 14.11%
5 Industrials 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RLI icon
176
RLI Corp
RLI
$5.26B
$2.53M 0.05%
80,292
-10,302
-11% -$319K
2014 Q4
8 quarters
ADP icon
177
Automatic Data Processing
ADP
$111B
$2.46M 0.05%
23,918
+1,418
+6% +$132K
2013 Q2
14 quarters
REGN icon
178
Regeneron Pharmaceuticals
REGN
$80.3B
$2.45M 0.05%
6,670
-62,736
-90% -$23.9M
2013 Q3
13 quarters
EQNR icon
179
Equinor
EQNR
$107B
$2.37M 0.05%
129,805
-7,791
-6% -$133K
2014 Q2
10 quarters
DEO icon
180
Diageo
DEO
$51.1B
$2.36M 0.05%
22,708
-698
-3% -$73.4K
2013 Q2
14 quarters
WEC icon
181
WEC Energy
WEC
$34.7B
$2.34M 0.05%
39,862
-4,690
-11% -$269K
2013 Q2
14 quarters
SAQ.CL
182
DELISTED
Saratoga Investment Corp.
SAQ.CL
$2.25M 0.04%
89,215
-800
-0.9% -$20.3K
2013 Q2
14 quarters
SPSC icon
183
SPS Commerce
SPSC
$3.06B
$2.24M 0.04%
64,126
+8,732
+16% +$298K
2013 Q2
14 quarters
VNQ icon
184
Vanguard Real Estate ETF
VNQ
$36.2B
$2.23M 0.04%
27,043
+2,915
+12% +$237K
2014 Q1
11 quarters
RGA icon
185
Reinsurance Group of America
RGA
$17.1B
$2.23M 0.04%
17,719
-1,481
-8% -$174K
2014 Q1
11 quarters
SDY icon
186
State Street SPDR S&P Dividend ETF
SDY
$21.1B
$2.22M 0.04%
25,960
+474
+2% +$39.8K
2016 Q3
1 quarter
RITM icon
187
Rithm Capital
RITM
$4.67B
$2.22M 0.04%
140,991
+90,991
+182% +$1.34M
2015 Q1
7 quarters
AGN
188
DELISTED
Allergan plc
AGN
$2.19M 0.04%
10,438
-3,961
-28% -$821K
2013 Q2
14 quarters
UNH icon
189
UnitedHealth
UNH
$354B
$2.18M 0.04%
13,646
+4,139
+44% +$618K
2013 Q2
14 quarters
IVE icon
190
iShares S&P 500 Value ETF
IVE
$49.4B
$2.18M 0.04%
21,518
+18,227
+554% +$1.78M
2015 Q4
4 quarters
UAL icon
191
United Airlines
UAL
$32.1B
$2.16M 0.04%
29,653
+117
+0.4% +$7.46K
2015 Q4
4 quarters
AM icon
192
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
$2.16M 0.04%
69,950
+125
+0.2% +$3.59K
2016 Q3
1 quarter
KO icon
193
Coca-Cola
KO
$394B
$2.14M 0.04%
51,720
-2,454
-5% -$102K
2013 Q2
14 quarters
NLY.PRD icon
194
DELISTED
Annaly Capital Management, Inc. 7.50% Series D Cumulative Redeemable Preferred Stock
NLY.PRD
$2.14M 0.04%
88,715
+150
+0.2% +$3.7K
2013 Q2
14 quarters
NVS icon
195
Novartis
NVS
$279B
$2.12M 0.04%
32,454
-1,523
-4% -$98.8K
2013 Q2
14 quarters
ASML icon
196
ASML
ASML
$645B
$2.11M 0.04%
18,838
-1,108
-6% -$116K
2014 Q1
11 quarters
ACHC icon
197
Acadia Healthcare
ACHC
$2.96B
$2.08M 0.04%
62,900
-468,120
-88% -$18.2M
2013 Q2
14 quarters
AMTX icon
198
Aemetis
AMTX
$105M
$2.06M 0.04%
1,479,231
+26,100
+2% +$42.5K
2014 Q2
10 quarters
NFLX icon
199
Netflix
NFLX
$293B
$2.04M 0.04%
165,120
+105,870
+179% +$1.25M
2015 Q2
6 quarters
FDX icon
200
FedEx
FDX
$68.6B
$2.03M 0.04%
10,919
+189
+2% +$34.7K
2013 Q2
14 quarters
6 7
8
9 10

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.22% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Geneva Advisors held 885 positions worth $5.12B, down 3.7% from $5.32B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors withdrew a net $200M in Q4 2016, closing 94 positions and reducing 309 holdings. Its most notable exit was Ventas, an estimated $42.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

Against the trend, Geneva Advisors opened a new position in Citizens Financial Group worth $28M.

  • Geneva Advisors's largest Q4 2016 buy was Citizens Financial Group: 786,703 shares worth $28M.
  • Geneva Advisors added most to Celgene Corp in Q4 2016, an estimated $25.9M increase.
  • Geneva Advisors's biggest Q4 2016 reduction was B/E Aerospace Inc, cutting an estimated $48.6M.
  • Geneva Advisors fully exited Ventas in Q4 2016, selling an estimated $42.2M.
  • Geneva Advisors's ten largest holdings make up 25% of its $5.12B portfolio in Q4 2016.
  • Geneva Advisors opened 102 new positions and closed 94 in Q4 2016.
  • Geneva Advisors's portfolio value fell 3.7% quarter-over-quarter to $5.12B.

Based on Geneva Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.